> top > projects > sonoma > docs > PubMed:20399956 > annotations
sonoma  

PubMed:20399956 JSONTXT 29 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
T-0 25-29 GENE denotes Shp2
T-1 33-44 CPA denotes development
T-2 49-55 DISEASE denotes cancer
T-3 73-91 PATHWAY denotes signaling pathways
T-4 101-109 VAR denotes mutation
T-5 153-159 REG denotes result
T-6 163-170 DISEASE denotes disease
T-7 197-201 GENE denotes Shp2
T-8 225-234 REG denotes regulator
T-9 273-300 MPA denotes cytokine receptor signaling
T-10 331-340 VAR denotes mutations
T-11 354-360 GENE denotes PTPN11
T-12 376-380 GENE denotes Shp2
T-13 387-393 REG denotes linked
T-14 397-403 DISEASE denotes Noonan
T-15 405-407 DISEASE denotes NS
T-16 413-430 DISEASE denotes LEOPARD syndromes
T-17 486-499 REG denotes characterized
T-18 503-516 CPA denotes short stature
T-19 518-538 CPA denotes craniofacial defects
T-20 589-593 GENE denotes Shp2
T-21 594-603 VAR denotes mutations
T-22 613-623 REG denotes associated
T-23 624-628 REG denotes with
T-24 652-664 DISEASE denotes malignancies
T-25 690-707 DISEASE denotes juvenile leukemia
T-26 709-741 DISEASE denotes juvenile myelomonocytic leukemia
T-27 743-747 DISEASE denotes JMML
T-28 758-760 DISEASE denotes NS
T-29 765-769 DISEASE denotes JMML
T-30 774-780 REG denotes caused
T-31 784-800 POSREG denotes gain-of-function
T-32 802-805 POSREG denotes GOF
T-33 807-816 VAR denotes mutations
T-34 820-824 GENE denotes Shp2
T-35 826-842 NEGREG denotes loss-of-function
T-36 844-847 NEGREG denotes LOF
T-37 849-858 VAR denotes mutations
T-38 877-887 REG denotes associated
T-39 893-909 DISEASE denotes LEOPARD syndrome
T-40 948-951 NEGREG denotes LOF
T-41 960-969 VAR denotes mutations
T-42 975-982 REG denotes allowed
T-43 1026-1030 GENE denotes Shp2
T-44 1031-1039 MPA denotes function
T-45 1082-1086 GENE denotes Shp2
T-46 1090-1108 PATHWAY denotes signaling pathways
T-47 1114-1121 REG denotes control
T-48 1145-1166 CPA denotes embryonic development
R-0 T-4 T-5 CauseOf mutation,result
R-1 T-6 T-5 ThemeOf disease,result
R-10 T-15 T-13 ThemeOf NS,linked
R-11 T-15 T-17 ThemeOf NS,characterized
R-12 T-16 T-13 ThemeOf LEOPARD syndromes,linked
R-13 T-16 T-17 ThemeOf LEOPARD syndromes,characterized
R-14 T-18 T-13 ThemeOf short stature,linked
R-15 T-18 T-17 ThemeOf short stature,characterized
R-16 T-19 T-13 ThemeOf craniofacial defects,linked
R-17 T-19 T-17 ThemeOf craniofacial defects,characterized
R-18 T-20 T-21 ThemeOf Shp2,mutations
R-19 T-21 T-22 CauseOf mutations,associated
R-2 T-7 T-8 ThemeOf Shp2,regulator
R-20 T-21 T-23 CauseOf mutations,with
R-21 T-24 T-22 ThemeOf malignancies,associated
R-22 T-24 T-23 ThemeOf malignancies,with
R-23 T-25 T-22 ThemeOf juvenile leukemia,associated
R-24 T-25 T-23 ThemeOf juvenile leukemia,with
R-25 T-26 T-22 ThemeOf juvenile myelomonocytic leukemia,associated
R-26 T-26 T-23 ThemeOf juvenile myelomonocytic leukemia,with
R-27 T-27 T-22 ThemeOf JMML,associated
R-28 T-27 T-23 ThemeOf JMML,with
R-29 T-28 T-30 ThemeOf NS,caused
R-3 T-9 T-8 ThemeOf cytokine receptor signaling,regulator
R-30 T-29 T-30 ThemeOf JMML,caused
R-31 T-33 T-30 CauseOf mutations,caused
R-32 T-33 T-31 CauseOf mutations,gain-of-function
R-33 T-33 T-35 CauseOf mutations,loss-of-function
R-34 T-34 T-33 ThemeOf Shp2,mutations
R-35 T-37 T-38 CauseOf mutations,associated
R-36 T-39 T-38 ThemeOf LEOPARD syndrome,associated
R-37 T-41 T-42 CauseOf mutations,allowed
R-38 T-43 T-44 ThemeOf Shp2,function
R-39 T-45 T-46 ThemeOf Shp2,signaling pathways
R-4 T-10 T-13 CauseOf mutations,linked
R-40 T-48 T-47 ThemeOf embryonic development,control
R-5 T-10 T-17 CauseOf mutations,characterized
R-6 T-11 T-10 ThemeOf PTPN11,mutations
R-7 T-12 T-10 ThemeOf Shp2,mutations
R-8 T-14 T-13 ThemeOf Noonan,linked
R-9 T-14 T-17 ThemeOf Noonan,characterized